Medical network - July 18 last week, the correction pharmaceutical group chairman XiuLaiGui involved in the news of the bribery case caught the attention of the industry. Judgment shows that he has to give the original two times jingyu county, jilin province, changbai Korean autonomous county, the county party committee secretary of the ChuLaiFu tonghua pharmaceutical co., LTD., the value of 250000 yuan.
Beijing news reporter with "bribe" and "medicine" as keywords, to the Chinese website written judgment of criminal judgment when combing, found that on January 1, 2016 to July 12, 2017, a total of 169 medical industry bribery case judgment, involving 438 medical related enterprises and individuals, occurs mostly in drug sales, circulation, bribery mainly for kickbacks and illegal bonus cash or gifts, pays for the families of the recipient, such as beer and skittles. Among them, both the liaoning cheng da creatures that listed companies, there are listed companies owned by the company, such as biological vaccine of Harbin pharmaceutical group company, the recipient, including government officials, the hospital leadership, etc.
Medical management of Beijing university, director of the center for international studies at Shi Lu article believes that the characteristics of the drug as a special commodity and the particularity of the operation mechanism of the pharmaceutical industry, perhaps was the cause of the high incidence of bribery in medicine industry.
Nearly two years seven listed companies involved in bribery case
By judgment in the "name" of the enterprise, there are 7 for listed companies, bribes total more than 2.41 million yuan. 7 companies, have several is bribing officials, in order to promote drug approval, project review. Among them, the liaoning cheng da biological Co., Ltd. (former name: liaoning cheng da biological technology Co., Ltd.) the greatest amount of bribery, to $1.09 million in the top of the list of bribery of the listed company, then followed by Beijing sinovac biotech Co., Ltd. (firm sinovac, operators), the unnamed biological pharmaceutical Co., Ltd., Walvax Biotechnology Co., Ltd., sinopharm Co., Ltd., east pharmaceutical (holding) Co., Ltd, jiangsu hengrui pharmaceutical companies.
In addition to seven listed companies involved in bribery case, there are a lot of listed companies, the company is also involved.
Among them, the Harbin pharmaceutical group's biological vaccine of Harbin pharmaceutical group company involved in two wider, as high as 7.59424 million yuan worth of bribery. Between 2008 and 2012, in the drug company and the government procurement activities of highly pathogenic avian influenza vaccine, hebi city, animal husbandry and veterinary service center illegally from Harbin pharmaceutical companies worth 4.002 million yuan can sell vaccine and 3.19224 million yuan in cash, and Harbin pharmaceutical companies are illegal profits of 7.11576 million yuan. Another is, in jiangxi province from 2008 to 2014, the forced vaccine bidding procurement and supply amount of vaccine distribution, Harbin pharmaceutical companies to prevent xx headquarters office in jiangxi province, ryu, deputy director of the bribes of 400000 yuan.
Yongjiaxian sanjing pharmaceutical co., LTD. In addition, Harbin pharmaceutical group, add marina yongjiaxian sanjing pharmaceutical co., LTD., yongjiaxian sanjing thousand crane pharmaceutical co., LTD., is also involved in the bribery cases, involving 4.72 million yuan. Among them, the yongjiaxian sanjing thousand crane pharmaceutical subsidiary heilongjiang thousand cranes parkson pharmaceutical co., LTD. (a set of two sets of team Sagittarius) on December 18, 2012 to December 2013, 19 day, by the financial department with false expenses, such as paper taking money from the unit normal CaiWuZhang bribery, paying kickbacks of $4.3668 million.
The Beijing news reporter also combed the same time inner foreign drug companies related situation, the results showed that more than 50 companies did not directly related to bribery, part of the bribery by elements of the sales company.
Medical field wider targeting senior hospital
The Beijing news reporter found, the management of medicine, medical equipment wholesale, sales and distribution company for corruption "high-risk groups". 438 companies involved in the judgment and the affiliated enterprise of the individual, this kind of company is at least 300, liupanshui raw pharmaceutical co., LTD., the maximum amount of bribery, is 10.2332 million yuan.
"These areas involves specific trading, corruption is the most part." An unnamed industry insider told the Beijing news reporter, "but the real money, may still enterprise."
It is important to note that the President, secretary of the hospital, and department head is the enterprise such as the main object of bribery.
Beijing news reporters combing case information network information found the people's procuratorate, January 1, 2017 solstice on July 11, 248 pieces of the medical profession bribery complaint, bribery are more than 200 people working in a hospital. Rough statistics, unveiled a specific position in the indictment of bribery, director/secretary has 67 people, receiving the most jobs, then followed by clinical laboratory, pharmacy, orthopaedic and medical QiXieKe, information and other departments.
On January 1, 2016 to July 12, 2017, a total of 169 medical industry bribery case judgment, relevant personnel involved more than 300 hospital, director/secretary of the level of those involved nearly 200, major is given priority to with cash, kickbacks, bribery way many hospitals involved in the name of the new fee, thank taking bribes.
Personal maximum amount of bribery is the second people's hospital of deyang city dean Tang Yuntao, illegally accepts a value of RMB 8.84 million, which took 6.97 million yuan together with the others.
And bribery of most enterprises is liupanshui raw pharmaceutical co., LTD. In order to get purchasing drugs business sign and timely settlement drugs, the business bribes in the form of rebates and -with 42, dean of the pharmacy and a section chief, shuicheng two county-level hospitals involved in liupanshui city and 33 institutes of health.
According to the people's procuratorate case information public disclosure of information, only to public in May 2016 in series of commercial bribery cases about health care, more than 110 dean for bribery.
Many officials to take bribes involve large sums of money involved in the enterprise
In the medical bribery case, responsible for relevant work of medical officials, due to its holding medicine project approval rights, medicine distribution network or hospital medicine instrument purchase contact control, also can become the focus of the pharmaceutical enterprise or individual sales personnel bribery object.
It is important to note that even though the official bribery case in the frequency is not high, only 16 cases, but the same officials took many medicine enterprises or individuals corruption and bribery, amount is huge, is the official bribery, bribery, the key characteristics different from other groups.
這16起案件涉及25名受賄官員，職位最高的是原國家食品藥品監督管理總局藥品注冊司生物制品注冊處處長和藥品審評中心副主任尹紅章，涉及遼寧成大、北京科興、云南沃森等8起行賄，金額超過300萬元。 其中一份判決書顯示，尹紅章于2007年至2015年間，伙同其子共同非法收受原遼寧成大生物技術有限公司總經理莊某給予109萬余元，不僅包括現金、匯款等方式，莊某還以發工資的形式，給實際并未去他另一家企業上班的尹紅章兒子每月發放工資。 In the sinovac, bribery case, Yin Gongzhang alone or together with his wife together with illegally accept, the amount of money for Yin a total of 550000 yuan. In addition, Yin Gongzhang from zhejiang tian yuan biological pharmaceutical co., LTD. The value of the former chairman of the board being given a 180000 yuan of ivory products. In 2016, Yin Gongzhang was sentenced to 10 years, $500000 fine.
The maximum amount of bribery is the original sichuan province health department medical administration, deputy director, director, emergency office director, who in sichuan province development planning commission KeJiaoChu director surin, using his position to, alone or with others has received others property for a total of 16.175 million yuan, surin personal income 12.425 million yuan.
The original bozhou city food and drug administration and drug safety supervision coco long Zheng Ruhai, bribes are far lower than surin, is 2.3677 million yuan, but up to 56 involving bribery event.
Some county in the other corrupt officials include county, county health bureau chief, etc. These officials often by helping pharmaceutical enterprises or individuals through medicine project examination and approval, or help with the hospitals, clinics, sales agreement for high rebates, table, etc.
S the voice
市場競爭激烈導致行賄案件高發
Against bribery case, the Beijing news reporter called include liaoning cheng da, anonymous biological medicine, yunnan Watson biopharmaceutical companies, such as, some businesses, such as zhejiang tianyuan, unknown biological medicine; 一些則告知需提供具體人名，否則無法轉接電話，如遼寧成大； Some companies require send interview outline in email form, such as yunnan biopharmaceutical Watson, were still not respond; And of enterprise is the media of bribery case, hang up the phone directly, such as burr biological products co., LTD., changchun sea YueYangKang pharmaceutical co., LTD., etc.
Hubei pharmaceutical co., LTD. The job is done only staff reply, according to company personnel changes frequently, not clear after occurrence of a wider, "the company for the salesman bribery management is strict, once found that bribery is dismissed."
The pharmaceutical industry could become hotspot bribery case? Medical management of Beijing university, director of the center for international studies at Shi Lu think, as a special commodity, medicine also has the market attributes, need through the market mechanism and market-oriented way of sales, but drug sales channels for the public medical institutions, drug comes with certain social and functional, government regulation is relatively strict. Enterprise products to enter the market and expanding consumption, must by regulators or medical institutions, and has certain competitive on the market at present, relatively competitive, also has the possibility to produce a series of problems.
"Two votes" can curb bribery still to be tested
As the medical industry anti-corruption efforts continue to strengthen, the enterprise to take gold sales problems become more and more attention. Last September, 23 pharmaceutical enterprise in fujian province and fujian province pharmaceutical industry association launched "to say no to drugs with gold sales phenomenon!" A joint initiative. At the end of last year, sinopharm tianjin co., LTD. And China resources respectively, tianjin pharmaceutical co., LTD. Has issued emergency notification, request by drug companies and business companies sell drugs in medical institutions, consumables reagent products such as activity, to the compliance management, not to the doctor and related personal various forms of kickbacks and rebates.
According to the requirements of the 2017 national health reform key task schedule, June 30 is reform pilot province of two votes (drugs from pharmaceutical factory sell to dealers open an invoice, dealers to sell to the hospital again open invoice, in order to reduce the circulation link layers of exploitation) deadline for papers, by the end of July, 11 the health of the provinces have introduced 10 provinces.
It was also regarded as pulled open the medicine circulation industry consolidation unfolds. Two votes to curb medical bribery effect how? The foregoing the personage inside course of study tells a reporter, I'm afraid it is difficult to curb bribery pharmaceutical industry completely, also need to pass test in actual operation.
Shi Lu wen said the two votes at this stage to curb, the pharmaceutical industry will have a role in the tax regulation is not in place at the same time, the situation of administrative means to be able to squeeze out some of the intermediate links, but the final solution also depends on the perfect mechanism of bribery issues. |
